Cigna Maintains FY Earnings Forecast: Adjusted Operating EPS at Least $24.70, Revenue At Least $190.00 Billion

• Cigna is maintaining its forecast for adjusted operating earnings per share (EPS) at least $24.70, with an estimate of $24.82.
• The company is expecting adjusted revenue to be at least $190.00 billion, up from an earlier estimate of at least $188.00 billion, with an estimate of $189.66 billion.
• Cigna is expecting medical customer growth of at least +1.40 million, up from an earlier estimate of at least +1.30 million.
• Cash flow from operations is expected to be at least $9.50 billion, up from an earlier estimate of at least $9.00 billion, with an estimate of $10.45 billion.
• The medical care ratio is expected to be 81.5% to 82.3%, with an estimate of 81.9%.
• In the second quarter, Cigna reported an adjusted operating EPS of $6.13, with an estimate of $5.95.
• The company reported adjusted revenue of $48.62 billion, with an estimate of $47.24 billion, and revenue of $48.59 billion, with an estimate of $46.99 billion.
• Global medical customers totaled 19.5 million, in line with the estimate of 19.5 million.
• The medical care ratio was 81.2%, slightly lower than the estimate of 81.5%.

Cigna Group/ on Smartkarma

Cigna Group has been receiving positive coverage from analysts. Baptista Research, an independent investment research network, recently released a report that highlighted the strong performance of the company in the last quarter. Revenues and earnings were both well above Wall Street expectations, with Evernorth, including pharmacy benefit services, Specialty Pharmacy, and Evernorth Care, retaining, expanding, and winning new relationships. Additionally, Cigna Healthcare’s health benefits platform achieved revenue and customer growth in the U.S. commercial, U.S. government, and international health businesses.

The report, written by independent analysts, was bullish in sentiment and focused on the company’s focus on affordability and pricing driving medical cost performance. The authors of the report also noted that the company’s key drivers have been able to bring value to their customers. With the strong performance in the last quarter, analysts are optimistic that Cigna Group will continue to provide value to their customers in the future.

A look at Cigna Group/ Smart Scores

The Cigna Group is an insurance company that provides life, accident, disability, supplemental, medicare, and dental insurance products and services to individuals, families, and businesses worldwide. According to the Smartkarma Smart Scores, the long-term outlook for the Cigna Group is positive. The company scores well on value, growth, momentum, and resilience, with a score of 3, 4, 4, and 3 respectively. The company’s dividend score, however, is lower at 2. Overall, the Cigna Group looks set to continue to provide dependable and reliable insurance services to its customers in the long-term.

The Cigna Group has a strong track record of providing quality services to its customers. With its strong scores on value, growth, momentum, and resilience, the company looks set to continue to grow and provide dependable and reliable services in the long-term. The company’s lower dividend score indicates that it is not as focused on providing dividends as other companies. However, with its strong overall outlook, the Cigna Group looks set to continue to provide reliable insurance services to its customers in the long-term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma